The race to develop effective cancer vaccines has entered a new phase, with late-stage trials from companies like Moderna ...

PFE's non-oncology portfolio draws focus in Q2, with strength in Vyndaqel and Nurtec offsetting some vaccine softness.

Cambridge, USA-based biotech Avalyn Pharma, which developing inhaled therapies for the treatment of life-threatening pulmonary diseases, has announced the closing of an oversubscribed $100 million ...

As the prosecution has not appealed the ruling, the acquittal of Ilze Viņķele for official misconduct has come into force.

The exanthema market is projected to grow from USD 1.39 billion in 2024 to USD 2.51 billion by 2034 at a CAGR of 6.10%. This growth is driven by risi ...

Clearlake Capital, Platinum Equity and EQT have made offers for Forward Air ( NASDAQ: FWRD ), according to a Reuters report ...

COVID-19 surge in the US! Find out why cases are increasing and get expert advice on how to protect yourself and loved ones.

Nikolay Shestak, partner at Zubr Capital, warns European venture capital must evolve to ensure deep tech thrives.

Discover how cutting-edge AI products are transforming industries, boosting innovation, and shaping Africa’s tech future and ...